Strengthening Families & Communities LLC’s Stoke Therapeutics STOK Stock Holding History

Strengthening Families & Communities LLC’s Portfolio STOK Stock Details STOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$654	Buy	+20	New	+$642	﹤0.01%	721

Other funds holding STOK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Strengthening Families & Communities LLC's STOK Position: Q2 2026 in Review

Strengthening Families & Communities LLC opened a new position in Stoke Therapeutics (STOK) in Q2 2026: 20 shares worth $654. The stake represents ﹤0.01% of the portfolio and ranks #721 among its holdings.

80 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

Strengthening Families & Communities LLC held 20 shares of Stoke Therapeutics worth $654 as of Q2 2026.
Stoke Therapeutics was a new Strengthening Families & Communities LLC position in Q2 2026.
Stoke Therapeutics made up ﹤0.01% of Strengthening Families & Communities LLC's portfolio in Q2 2026, its #721 holding.
80 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Strengthening Families & Communities LLC's 13F filing for Q2 2026, filed 11 Aug 2026.